Market Overview

Benzinga's Top #PreMarket Gainers

Related OPHT
Chardan Rates Regeneron A Sell, Advises Caution
12 Biggest Mid-Day Losers For Friday
Regeneron Pharmaceuticals Falls As Combo Therapy Worse Than Eylea Alone (Investor's Business Daily)
Related CLVS
Chasing Takeover Rumors Can Be Hazardous To Your Portfolio
Benzinga's Volume Movers
Novel Checkpoints Add To The Parp Showdown (Seeking Alpha)

Ophthotech (NASDAQ: OPHT) soared 23.97% to $39.00 in the pre-market trading after the company reported that it has entered into an ex-US licensing and commercialization deal with Novartis Pharmaceuticals.

NewLead Holdings (NASDAQ: NEWL) shares jumped 12.82% to $2.20 after surging 209.72% on Monday.

Dendreon (NASDAQ: DNDN) shares jumped 10.28% to $2.36 in pre-market trading after the company announced the presentation of PROVENGE ProACT and IMPACT studies data.

Clovis Oncology (NASDAQ: CLVS) shares climbed 7.45% to $61.00 in the pre-market trading session after the company reported that it has received breakthrough therapy designation for CO-1686.

AstraZeneca PLC (NYSE: AZN) shares gained 1.95% to $72.02 in pre-market trading on investor call for talks with Pfizer (NYSE: PFE).

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (AZN + CLVS)

View Comments and Join the Discussion!